BDBM213849 6-{[(1r)-1- cyclobutylethyl]amino}- 7-[3-fluoro-4- (trifluoromethoxy)benzyl]- 8-[3-methyl-4-(1- methylethyl)pyridin-2- yl]-7h-purine-2- carboxylic acid::US9540377, 1.91

SMILES CC(C)c1ccnc(-c2nc3nc(nc(N[C@H](C)C4CCC4)c3n2Cc2ccc(OC(F)(F)F)c(F)c2)C(O)=O)c1C

InChI Key InChIKey=AHEVSJWGKXEWQW-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 213849   

TargetE3 ubiquitin-protein ligase Mdm2 [17-125](Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 213849BDBM213849(US9540377, 1.91 | 6-{[(1r)-1- cyclobutylethyl]amin...)
Affinity DataIC50: 22.3nMT: 2°CAssay Description:An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2018
Entry Details
US Patent